These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7259931)

  • 1. Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.
    Rowell FJ; Hui SM; Fairbairn AF; Eccleston D
    Br J Clin Pharmacol; 1981 Apr; 11(4):377-82. PubMed ID: 7259931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
    Rao ML; Brown WA
    Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital.
    Greendyke RM; Gulya A
    J Clin Psychiatry; 1988 Mar; 49(3):105-7. PubMed ID: 3346197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays.
    Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M
    Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations.
    Greendyke RM; Kanter DR
    J Clin Psychopharmacol; 1987 Jun; 7(3):178-82. PubMed ID: 3597804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled double-blind study of haloperidol versus thioridazine in the treatment of restless mentally subnormal patients. Serum levels and clinical effects.
    Väisänen K; Rimón R; Räisänen P; Viukari M
    Acta Psychiatr Belg; 1979; 79(6):673-85. PubMed ID: 554446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Mihara K; Suzuki A; Inoue Y; Kaneko S
    J Clin Psychopharmacol; 2003 Oct; 23(5):435-40. PubMed ID: 14520118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood levels of haloperidol in schizophrenic patients.
    Shvartsburd A; Dekirmenjian H; Smith RC
    J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anticonvulsants on plasma haloperidol and thioridazine levels.
    Linnoila M; Viukari M; Vaisanen K; Auvinen J
    Am J Psychiatry; 1980 Jul; 137(7):819-21. PubMed ID: 6770696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.
    Shvartsburd A; Nwokeafor V; Smith RC
    Psychopharmacology (Berl); 1984; 82(1-2):55-61. PubMed ID: 6420831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum haloperidol determinations in psychiatric patients. Comparison of methods and correlation with serum prolactin level.
    Rubin RT; Forsman A; Heykants J; Ohman R; Tower B; Michiels M
    Arch Gen Psychiatry; 1980 Sep; 37(9):1069-74. PubMed ID: 7416906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor techniques in the study of plasma levels of neuroleptics and antidepressant drugs.
    Smith RC; Vroulis G; Misra CH; Schoolar J; DeJohn C; Korivi P; Leelavathi DE; Arzu D
    Commun Psychopharmacol; 1980; 4(6):451-65. PubMed ID: 7297052
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum haloperidol levels of schizophrenics receiving treatment for tuberculosis.
    Takeda M; Nishinuma K; Yamashita S; Matsubayashi T; Tanino S; Nishimura T
    Clin Neuropharmacol; 1986; 9(4):386-97. PubMed ID: 3731135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients.
    Rimón R; Averbuch I; Rozick P; Fijman-Danilovich L; Kara T; Dasberg H; Ebstein RP; Belmaker RH
    Psychopharmacology (Berl); 1981; 73(2):197-9. PubMed ID: 6785816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between psychotropic drug dosage, plasma drug concentration, and prolactin levels in nursing home residents.
    Cohen-Mansfield J; Taylor L; Woosley R; Lipson S; Werner P; Billig N
    Ther Drug Monit; 2000 Dec; 22(6):688-94. PubMed ID: 11128236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum haloperidol and neuroleptic receptor levels in chronic psychosis.
    Cannon DJ; McMillan DE; Newton JE; Fody EP; Metzer WS; Claybrook M; Couch L; Paige SR
    Ann Clin Lab Sci; 1988; 18(5):378-83. PubMed ID: 3178137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug holidays and serum haloperidol levels in schizophrenic patients.
    McMillan DE; Fody EP; Couch L; Harrison RH; Newton JE; Reese WG
    J Clin Psychiatry; 1986 Jul; 47(7):373-4. PubMed ID: 3722135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol, thioridazine and placebo in mentally subnormal patients-serum levels and clinical effects.
    Väisänen K; Viukari M; Rimón R; Räisänen P
    Acta Psychiatr Scand; 1981 Mar; 63(3):262-71. PubMed ID: 7015792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.